Brief: Sun Pharma Advanced Research Enters Into Licensing Agreement With Biomodifying
Dec 3 (Reuters) - Sun Pharma Advanced Research Co Ltd
SPRC.NS :
* HAS ENTERED INTO AN AGREEMENT WITH BIOMODIFYING LLC
* AGREEMENT TO EXCLUSIVELY LICENSE BIOMODIFYING'S
INTELLECTUAL
PROPERTY
* UNDER AGREEMENT, BIOMODIFYING IS ELIGIBLE FOR AN UP-FRONT
PAYMENT, MILESTONE PAYMENTS, ROYALTIES ON SALES
* CO WILL PAY BIOMODIFYING A PERCENT OF PAYMENTS GOT FOR
SUBLICENSES OF LICENSED IP
Source text for Eikon: ID:nBSE54HYbH
Further company coverage: SPRC.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Sun Pharma Advanced Research
See all newsAdvisory: Alert incorrectly tagged to Sun Pharma Advanced Research withdrawn
Brief: Sun Pharma Advanced Research Appoints Anil Raghavan As MD And CEO Effective August 11
Brief: Sun Pharma Advanced Research Says Ocuvex Therapeutics Gets Complete Response Letter For PDP-716 NDA
India's Sun Pharma Advanced Research jumps after swinging to Q4 profit
Brief: Sun Pharma Advanced Research March-Quarter Consol Profit 17.61 Billion Rupees